GGrantIndex
← Leaderboards

Zahra Toossi

Case Western Reserve University

$8,027,247
Attributed
$8,027,247
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $694.1K · FY200514
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14

Funding mix

By agency

NIH$8,027,247 · 10

By mechanism

R01$5,693,245 · 3
P30$1,915,651 · 3
R56$304,923 · 1
M01$102,990 · 2
T35$10,438 · 1

Top collaborators

No co-investigators on record.

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Mycobacterium Tuberculosis

Research focus

Mycobacterium TuberculosisTuberculosisPathogenCellsMononuclearMacrophageBaseResearch PersonnelLaboratoriesUgandaResourcesArtsChemokineTranscriptional ActivationHiv-1ProductionClinical ResearchOpportunistic InfectionsCytokineHuman SubjectMonocytePositive Transcriptional Elongation Factor BCd4 Positive T LymphocytesPathogenesis

Grant awards (34)

Impact of Tuberculosis on HIV Disease$374,917
R01 · FY2014 · HL · contact PI
Impact of Tuberculosis on HIV Disease$362,536
R01 · FY2013 · HL · contact PI
Virology and Microbial Pathogenesis Core$130,064
P30 · FY2013 · AI · contact PI
Impact of Tuberculosis on HIV Disease$384,916
R01 · FY2012 · HL · contact PI
Virology and Microbial Pathogenesis Core$199,462
P30 · FY2012 · AI · contact PI
Impact of Tuberculosis on HIV Disease$378,469
R01 · FY2011 · HL · contact PI
Virology, Proteomics and Microbial Pathogenesis$309,611
P30 · FY2011 · AI · contact PI
Impact of Tuberculosis on HIV Disease$385,679
R01 · FY2010 · HL · contact PI
Virology, Proteomics and Microbial Pathogenesis$298,030
P30 · FY2010 · AI · contact PI
Research Training in Heart, Lung, Blood & Sleep Diseases$10,438
T35 · FY2010 · HL · contact PI
Impact of Tuberculosis on HIV Disease$304,923
R56 · FY2009 · HL · contact PI
Biosafety$117,156
P30 · FY2009 · AI · contact PI
Impact of Tuberculosis on HIV Disease$344,085
R01 · FY2008 · HL · contact PI
CORE--Biosafety Core$218,287
P30 · FY2008 · AI · contact PI
Impact of Tuberculosis on HIV Disease$344,085
R01 · FY2007 · HL · contact PI
CORE--Biosafety Core$213,838
P30 · FY2007 · AI · contact PI
Impact of Tuberculosis on HIV Disease$11,340
R01 · FY2007 · HL · contact PI
Impact of Tuberculosis on HIV Disease$354,362
R01 · FY2006 · HL · contact PI
CORE--Biosafety Core$147,590
P30 · FY2006 · AI · contact PI
THE LUNG IN HIV DISEASE AND TUBERCULOSIS$39,876
M01 · FY2006 · RR · contact PI
Impact of Tuberculosis on HIV Disease$9,820
R01 · FY2006 · HL · contact PI
Impact of Tuberculosis on HIV Disease$362,890
R01 · FY2005 · HL
CORE--Biosafety Core$143,864
P30 · FY2005 · AI
THE LUNG IN HIV DISEASE AND TUBERCULOSIS$44,260
M01 · FY2005 · RR
Impact of Tuberculosis on HIV Disease$376,140
R01 · FY2004 · HL
CORE--Biosafety Core$137,749
P30 · FY2004 · AI
The lung in HIV disease and tuberculosis$18,854
M01 · FY2004 · RR
IMPACT OF TUBERCULOSIS ON HIV DISEASE$303,404
R01 · FY2003 · HL
IMPACT OF TUBERCULOSIS ON HIV DISEASE$295,659
R01 · FY2002 · HL
IMPACT OF TUBERCULOSIS ON HIV DISEASE$288,164
R01 · FY2001 · HL
IMMUNOSUPPRESSION IN MYCOBACTERIAL DISEASES$276,707
R01 · FY2001 · AI
ACTIVATION OF HIV-1 BY SMOKING AND TUBERCULOSIS$292,750
R01 · FY2000 · HL
IMPACT OF TUBERCULOSIS ON HIV DISEASE$278,675
R01 · FY2000 · HL
IMMUNOSUPPRESSION IN MYCOBACTERIAL DISEASES$268,647
R01 · FY2000 · AI